(Hypertension. 1995;25:848-853.)
© 1995 American Heart Association, Inc.
Articles |
Circulating Nitric Oxide (Nitrite/Nitrate) Levels in Postmenopausal Women Substituted With 17ß-Estradiol and Norethisterone Acetate
A Two-Year Follow-up Study
From the Department of Obstetrics and Gynecology, Clinic of Endocrinology, University Hospital, Zurich, Switzerland (M.R., B.I., P.J.K.); and the Department of Medicine, Center for Clinical Pharmacology, University of Pittsburgh (Pa) Medical Center (E.K.J., R.K.D.).
Correspondence to Dr Raghvendra K. Dubey, Center for Clinical Pharmacology, Department of Medicine, 623 Scaife Hall, University of Pittsburgh Medical Center, Pittsburgh, Pa 15213-2582.
Abstract Postmenopausal women (PMW) have an increased risk of cardiovascular disease that is attenuated by hormone replacement therapy (HRT). Inasmuch as hypertension and atherosclerosis are associated with diminished endothelium-derived nitric oxide (NO), we investigated whether HRT augments NO release in PMW. We determined serum levels of nitrite/nitrate (NO2+NO3) at baseline and during the 6th, 12th, and 24th months of the study in two groups of PMW. One group (HRT-PMW, n=13) received continuous transdermal administration of 17ß-estradiol (Estraderm-TTS-50) supplemented with oral norethisterone acetate (NETA) on days 1 through 12 of each month, and the other group (control PMW, n=13) did not receive HRT. Blood samples in the HRT-PMW group were collected without regard to whether subjects were taking NETA at the time of blood sampling. Serum NO2+NO3 levels increased in HRT-PMW for the duration of the study, whereas serum NO2+NO3 levels remained unchanged in control PMW. When all samples regardless of timing of collection with respect to NETA treatment were included in the statistical analysis, the change in NO2+NO3 levels in HRT-PMW was significantly greater compared with the change in control PMW (P=.037). Likewise, when only those samples collected when estradiol-treated subjects were not taking oral NETA were included in the statistical analysis, the change in NO2+NO3 levels in the HRT-PMW group remained significant (P=.047) compared with control PMW. In contrast, when only those samples collected when estradiol-treated subjects were taking NETA were included in the analysis, the change in NO2+NO3 levels in the HRT-PMW group was not significant (P=.23) compared with control PMW. These results indicate that HRT increases NO levels in PMW, an effect that may contribute to the cardiovascular protection afforded by HRT in PMW. In addition, our data suggest, but do not prove, that concomitant administration of a progestin may attenuate the beneficial effects of estrogen replacement therapy with regard to NO release.
Key Words: nitric oxide • estradiol • norethindrone • progestational hormones • menopause • cardiovascular diseases
This article has been cited by other articles:
 |
|
 |
|
  M. R. O'Neil, G. P. Lardy, L. P. Reynolds, J. S. Caton, and K. A. Vonnahme Impacts of linseed meal and estradiol-17{beta} on mass, cellularity, angiogenic factors, and vascularity of the jejunum J Anim Sci, November 1, 2008; 86(11): 3014 - 3022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Pinna, A. Cignarella, P. Sanvito, V. Pelosi, and C. Bolego Prolonged Ovarian Hormone Deprivation Impairs the Protective Vascular Actions of Estrogen Receptor {alpha}Agonists Hypertension, April 1, 2008; 51(4): 1210 - 1217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. van Deel, D. Merkus, R. van Haperen, M. C. de Waard, R. de Crom, and D. J. Duncker Vasomotor control in mice overexpressing human endothelial nitric oxide synthase Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1144 - H1153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. D. Zoma, R. S. Baker, J. L. Mershon, and K. E. Clark Hemodynamic effects of acute and repeated exposure to raloxifene in ovariectomized sheep Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1216 - H1225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Ross, M. Chauhan, P. R. Gangula, L. Reed, C. Thota, and C. Yallampalli Female Sex Steroids Increase Adrenomedullin-Induced Vasodilation by Increasing the Expression of Adrenomedullin2 Receptor Components in Rat Mesenteric Artery Endocrinology, January 1, 2006; 147(1): 389 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Shibata, T. Nabika, H. Moriyama, J. Masuda, and S. Kobayashi Correlation of NO Metabolites and 8-Iso-Prostaglandin F2a With Periventricular Hyperintensity Severity Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1659 - 1663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Jose, M. U. Moreno, S. Olivan, O. Beloqui, A. Fortuno, J. Diez, and G. Zalba Functional Effect of the p22phox -930A/G Polymorphism on p22phox Expression and NADPH Oxidase Activity in Hypertension Hypertension, August 1, 2004; 44(2): 163 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-S. Wang, C.-J. Wang, Y.-J. Chen, Y.-T. Huang, H.-C. Huang, P.-R. Chang, Y.-C. Sun, and K. D. Yang Nitric Oxide Donor Increases Osteoprotegerin Production and Osteoclastogenesis Inhibitory Activity in Bone Marrow Stromal Cells from Ovariectomized Rats Endocrinology, May 1, 2004; 145(5): 2148 - 2156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Dubey, D. G. Gillespie, M. Grogli, H. J. Kloosterboer, and B. Imthurn Tibolone and Its Metabolites Induce Antimitogenesis in Human Coronary Artery Smooth Muscle Cells: Role of Estrogen, Progesterone, and Androgen Receptors J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 852 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Nikander, M. Metsa-Heikkila, A. Tiitinen, and O. Ylikorkala Evidence of a Lack of Effect of a Phytoestrogen Regimen on the Levels of C-Reactive Protein, E-Selectin, and Nitrate in Postmenopausal Women J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5180 - 5185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Attia, R. Goldschmeding, M. A. Attia, P. Boer, H. A. Koomans, and J. A. Joles Male gender increases sensitivity to renal injury in response to cholesterol loading Am J Physiol Renal Physiol, April 1, 2003; 284(4): F718 - F726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Chambliss and P. W. Shaul Estrogen Modulation of Endothelial Nitric Oxide Synthase Endocr. Rev., October 1, 2002; 23(5): 665 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Sardo, M. Castaldo, M. Cinquegrani, M. Bonaiuto, A. Maesano, A. Versace, M. Spadaro, S. Campo, G. Nicocia, D. Altavilla, et al. Effects of Atorvastatin Treatment on sICAM-1 and Plasma Nitric Oxide Levels in Hypercholesterolemic Subjects Clinical and Applied Thrombosis/Hemostasis, July 1, 2002; 8(3): 257 - 263. [Abstract] [PDF]
|
|
|
|
|
|
S. Nasreen, T. Nabika, H. Shibata, H. Moriyama, K. Yamashita, J. Masuda, and S. Kobayashi T-786C Polymorphism in Endothelial NO Synthase Gene Affects Cerebral Circulation in Smokers: Possible Gene-Environmental Interaction Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 605 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Dubey, S. Oparil, B. Imthurn, and E. K. Jackson Sex hormones and hypertension Cardiovasc Res, February 15, 2002; 53(3): 688 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz Changes in Proinflammatory Cytokine Activity after Menopause Endocr. Rev., February 1, 2002; 23(1): 90 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Vita and J. F. Keaney Jr Hormone Replacement Therapy and Endothelial Function: The Exception That Proves the Rule? Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 1867 - 1869. [Full Text] [PDF]
|
|
|
|
|
|
A. Saitta, D. Altavilla, D. Cucinotta, N. Morabito, N. Frisina, F. Corrado, R. D'Anna, A. Lasco, G. Squadrito, A. Gaudio, et al. Randomized, Double-Blind, Placebo-Controlled Study on Effects of Raloxifene and Hormone Replacement Therapy on Plasma NO Concentrations, Endothelin-1 Levels, and Endothelium-Dependent Vasodilation in Postmenopausal Women Arterioscler. Thromb. Vasc. Biol., September 1, 2001; 21(9): 1512 - 1519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Xiao, L. Xia-Zhang, M. Ferin, and S. L. Wardlaw Differential Effects of Estradiol on the Adrenocorticotropin Responses to Interleukin-6 and Interleukin-1 in the Monkey Endocrinology, July 1, 2001; 142(7): 2736 - 2741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ekerhovd, A. Enskog, K. Caidahl, N. Klintland, L. Nilsson, M. Brannstrom, and A. Norstrom Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome Hum. Reprod., July 1, 2001; 16(7): 1334 - 1339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Puder, P. U. Freda, R. S. Goland, and S. L. Wardlaw Estrogen Modulates the Hypothalamic-Pituitary-Adrenal and Inflammatory Cytokine Responses to Endotoxin in Women J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2403 - 2408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Sharma, V. Homuth, and F. C. Luft Hormone replacement therapy and blood pressure in normotensive and hypertensive women Nephrol. Dial. Transplant., May 1, 2001; 16(5): 888 - 890. [Full Text] [PDF]
|
|
|
|
|
|
H. L. Rupnow, T. M. Phernetton, C. E. Shaw, M. L. Modrick, I. M. Bird, and R. R. Magness Endothelial vasodilator production by uterine and systemic arteries. VII. Estrogen and progesterone effects on eNOS Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1699 - H1705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Gonzales, B. R. Walker, and N. L. Kanagy 17{beta}-Estradiol increases nitric oxide-dependent dilation in rat pulmonary arteries and thoracic aorta Am J Physiol Lung Cell Mol Physiol, March 1, 2001; 280(3): L555 - L564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Dubey and E. K. Jackson Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms Am J Physiol Renal Physiol, March 1, 2001; 280(3): F365 - F388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Dubey, E. K. Jackson, P. J. Keller, B. Imthurn, and M. Rosselli Estradiol Metabolites Inhibit Endothelin Synthesis by an Estrogen Receptor-Independent Mechanism Hypertension, February 1, 2001; 37(2): 640 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Aguirre, L. Buttery, M. O'Shaughnessy, F. Afzal, I. Fernandez de Marticorena, M. Hukkanen, P. Huang, I. MacIntyre, and J. Polak Endothelial Nitric Oxide Synthase Gene-Deficient Mice Demonstrate Marked Retardation in Postnatal Bone Formation, Reduced Bone Volume, and Defects in Osteoblast Maturation and Activity Am. J. Pathol., January 1, 2001; 158(1): 247 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Hernandez, J. L. Delgado, J. Diaz, T. Quesada, M. J. G. Teruel, M. C. Llanos, and L. F. Carbonell 17beta -Estradiol prevents oxidative stress and decreases blood pressure in ovariectomized rats Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2000; 279(5): R1599 - R1605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Noris, M. Todeschini, S. Zappella, S. Bonazzola, C. Zoja, D. Corna, F. Gaspari, F. Marchetti, S. Aiello, and G. Remuzzi 17beta -Estradiol corrects hemostasis in uremic rats by limiting vascular expression of nitric oxide synthases Am J Physiol Renal Physiol, October 1, 2000; 279(4): F626 - F635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Dubey, E. K. Jackson, D. G. Gillespie, L. C. Zacharia, B. Imthurn, and P. J. Keller Clinically Used Estrogens Differentially Inhibit Human Aortic Smooth Muscle Cell Growth and Mitogen-Activated Protein Kinase Activity Arterioscler. Thromb. Vasc. Biol., April 1, 2000; 20(4): 964 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Case and C. A. Davison Estrogen Alters Relative Contributions of Nitric Oxide and Cyclooxygenase Products to Endothelium-Dependent Vasodilation J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 524 - 530. [Abstract] [Full Text]
|
|
|
|
|
|
K. Sudhir and P. A. Komesaroff Cardiovascular Actions of Estrogens in Men J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3411 - 3415. [Full Text] [PDF]
|
|
|
|
|
|
V. E. Laubach, P. L. Foley, K. S. Shockey, C. G. Tribble, and I. L. Kron Protective roles of nitric oxide and testosterone in endotoxemia: evidence from NOS-2-deficient mice Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2211 - H2218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Stacey, P. Korkia, M. V. J. Hukkanen, J. M. Polak, and O. M. Rutherford Decreased Nitric Oxide Levels and Bone Turnover in Amenorrheic Athletes with Spinal Osteopenia J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3056 - 3061. [Abstract] [Full Text]
|
|
|
|
|
|
G. G. Geary, D. N. Krause, and S. P. Duckles Estrogen reduces myogenic tone through a nitric oxide-dependent mechanism in rat cerebral arteries Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H292 - H300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Nekooeian and C. C. Y. Pang Estrogen restores role of basal nitric oxide in control of vascular tone in rats with chronic heart failure Am J Physiol Heart Circ Physiol, June 1, 1998; 274(6): H2094 - H2099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Sorensen, I. Dorup, A. P. Hermann, and L. Mosekilde Combined Hormone Replacement Therapy Does Not Protect Women Against the Age-Related Decline in Endothelium-Dependent Vasomotor Function Circulation, April 7, 1998; 97(13): 1234 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Hernandez, J. L. Delgado, L. F. Carbonell, M. C. Perez, and T. Quesada Hemodynamic effect of 17beta -estradiol in absence of NO in ovariectomized rats: role of angiotensin II Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1998; 274(4): R970 - R978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Taylor, T. D. Williams, D. R. Seals, and K. P. Davy Low-frequency arterial pressure fluctuations do not reflect sympathetic outflow: gender and age differences Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1194 - H1201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Huang, D. Sun, G. Kaley, and A. Koller Estrogen Preserves Regulation of Shear Stress by Nitric Oxide in Arterioles of Female Hypertensive Rats Hypertension, January 1, 1998; 31(1): 309 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Dubey, D. G. Gillespie, E. K. Jackson, and P. J. Keller 17{beta}-Estradiol, Its Metabolites, and Progesterone Inhibit Cardiac Fibroblast Growth Hypertension, January 1, 1998; 31(1): 522 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. F. Skafar, R. Xu, J. Morales, J. Ram, and J. R. Sowers Female Sex Hormones and Cardiovascular Disease in Women J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3913 - 3918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Guetta, A. A. Quyyumi, A. Prasad, J. A. Panza, M. Waclawiw, and R. O. Cannon III The Role of Nitric Oxide in Coronary Vascular Effects of Estrogen in Postmenopausal Women Circulation, November 4, 1997; 96(9): 2795 - 2801. [Abstract] [Full Text]
|
|
|
|
|
|
X. L. Wang, M. C. Mahaney, A. Siew. Sim, J. Wang, J. Wang, J. Blangero, L. Almasy, R. B. Badenhop, and D. E. L. Wilcken Genetic Contribution of the Endothelial Constitutive Nitric Oxide Synthase Gene to Plasma Nitric Oxide Levels Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3147 - 3153. [Abstract] [Full Text]
|
|
|
|
|
|
C. R. White, J. Shelton, S.-J. Chen, V. Darley-Usmar, L. Allen, C. Nabors, P. W. Sanders, Y.-F. Chen, and S. Oparil Estrogen Restores Endothelial Cell Function in an Experimental Model of Vascular Injury Circulation, September 2, 1997; 96(5): 1624 - 1630. [Abstract] [Full Text]
|
|
|
|
|
|
S. Oparil, R. L. Levine, S.-J. Chen, J. Durand, and Y.F. Chen Sexually Dimorphic Response of the Balloon-Injured Rat Carotid Artery to Hormone Treatment Circulation, March 4, 1997; 95(5): 1301 - 1307. [Abstract] [Full Text]
|
|
|
|
|
|
B. Imthurn, M. Rosselli, A. W. Jaeger, P. J. Keller, and R. K. Dubey Differential Effects of Hormone-Replacement Therapy on Endogenous Nitric Oxide (Nitrite/Nitrate) Levels in Postmenopausal Women Substituted with 17{beta}-Estradiol Valerate and Cyproterone Acetate or Medroxyprogesterone Acetate J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 388 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. D. Kim, B. Chen, J. Beauregard, P. Kouretas, G. Thomas, M. Y. Farhat, A. K. Myers, and D. E. Lees 17ß-Estradiol Prevents Dysfunction of Canine Coronary Endothelium and Myocardium and Reperfusion Arrhythmias After Brief Ischemia/Reperfusion Circulation, December 1, 1996; 94(11): 2901 - 2908. [Abstract] [Full Text]
|
|
|
|
|
|
R. L. Levine, S.-J. Chen, J. Durand, Y.-F. Chen, and S. Oparil Medroxyprogesterone Attenuates Estrogen-Mediated Inhibition of Neointima Formation After Balloon Injury of the Rat Carotid Artery Circulation, November 1, 1996; 94(9): 2221 - 2227. [Abstract] [Full Text]
|
|
|
|
|
|
S. Taddei, A. Virdis, L. Ghiadoni, P. Mattei, I. Sudano, G. Bernini, S. Pinto, and A. Salvetti Menopause Is Associated With Endothelial Dysfunction in Women Hypertension, October 1, 1996; 28(4): 576 - 582. [Abstract] [Full Text]
|
|
|
|
|
|
K. Sudhir, G. L. Jennings, J. W. Funder, and P. A. Komesaroff Estrogen Enhances Basal Nitric Oxide Release in the Forearm Vasculature in Perimenopausal Women Hypertension, September 1, 1996; 28(3): 330 - 334. [Abstract] [Full Text]
|
|
|
|
|
|
V. Guetta and R. O. Cannon III Cardiovascular Effects of Estrogen and Lipid-Lowering Therapies in Postmenopausal Women Circulation, May 15, 1996; 93(10): 1928 - 1937. [Full Text]
|
|
|
|
|
|
M. Gerhard and P. Ganz How Do We Explain the Clinical Benefits of Estrogen? : From Bedside to Bench Circulation, July 1, 1995; 92(1): 5 - 8. [Full Text]
|
|
|
|
|
|
S. Nasreen, T. Nabika, H. Shibata, H. Moriyama, K. Yamashita, J. Masuda, and S. Kobayashi T-786C Polymorphism in Endothelial NO Synthase Gene Affects Cerebral Circulation in Smokers: Possible Gene-Environmental Interaction Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 605 - 610. [Abstract] [Full Text] [PDF]
|
|